Bristol-Myers Squibb Provides Update on Part 2 of CheckMate -227
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall St falls as tech earnings spark AI spending worries and oil hits $100
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
Bristol-Myers Squibb (BMY) Shares Decline After Part 2 of Phase 3 CheckMate -227 Did Not Meet Primary Endpoint
July 24, 2019 4:55 PM EDTBristol-Myers Squibb (NYSE: BMY) Shares Decline After Part 2 of Phase 3 CheckMate -227 Did Not Meet Primary Endpoint
Shares declined 4.6%
... More